Logo image of NMRK

NEWMARK GROUP INC-CLASS A (NMRK) Stock Fundamental Analysis

NASDAQ:NMRK - Nasdaq - US65158N1028 - Common Stock

13.79  +0.5 (+3.76%)

After market: 13.79 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to NMRK. NMRK was compared to 65 industry peers in the Real Estate Management & Development industry. There are concerns on the financial health of NMRK while its profitability can be described as average. NMRK is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

NMRK had positive earnings in the past year.
NMRK had a negative operating cash flow in the past year.
In the past 5 years NMRK has always been profitable.
In multiple years NMRK reported negative operating cash flow during the last 5 years.
NMRK Yearly Net Income VS EBIT VS OCF VS FCFNMRK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B

1.2 Ratios

NMRK has a Return On Assets of 1.05%. This is in the better half of the industry: NMRK outperforms 68.85% of its industry peers.
NMRK has a Return On Equity of 4.47%. This is in the better half of the industry: NMRK outperforms 73.77% of its industry peers.
NMRK has a Return On Invested Capital of 2.47%. This is in the better half of the industry: NMRK outperforms 67.21% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NMRK is significantly above the industry average of 4.84%.
The 3 year average ROIC (10.15%) for NMRK is well above the current ROIC(2.47%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.05%
ROE 4.47%
ROIC 2.47%
ROA(3y)5.78%
ROA(5y)4.47%
ROE(3y)22.9%
ROE(5y)19.37%
ROIC(3y)10.15%
ROIC(5y)8.54%
NMRK Yearly ROA, ROE, ROICNMRK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40 50

1.3 Margins

With a decent Profit Margin value of 2.00%, NMRK is doing good in the industry, outperforming 65.57% of the companies in the same industry.
In the last couple of years the Profit Margin of NMRK has declined.
NMRK has a better Operating Margin (5.72%) than 72.13% of its industry peers.
In the last couple of years the Operating Margin of NMRK has declined.
The Gross Margin of NMRK (98.92%) is better than 98.36% of its industry peers.
NMRK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.72%
PM (TTM) 2%
GM 98.92%
OM growth 3Y-23.16%
OM growth 5Y-20.65%
PM growth 3Y-22.41%
PM growth 5Y-19.06%
GM growth 3Y0.03%
GM growth 5Y0.04%
NMRK Yearly Profit, Operating, Gross MarginsNMRK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NMRK is still creating some value.
Compared to 1 year ago, NMRK has more shares outstanding
NMRK has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NMRK has a worse debt to assets ratio.
NMRK Yearly Shares OutstandingNMRK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
NMRK Yearly Total Debt VS Total AssetsNMRK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

NMRK has an Altman-Z score of 1.32. This is a bad value and indicates that NMRK is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.32, NMRK is in line with its industry, outperforming 49.18% of the companies in the same industry.
NMRK has a Debt/Equity ratio of 1.50. This is a high value indicating a heavy dependency on external financing.
NMRK has a Debt to Equity ratio of 1.50. This is in the lower half of the industry: NMRK underperforms 70.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACC0.32
WACC7.7%
NMRK Yearly LT Debt VS Equity VS FCFNMRK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B

2.3 Liquidity

NMRK has a Current Ratio of 1.02. This is a normal value and indicates that NMRK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.02, NMRK is doing worse than 70.49% of the companies in the same industry.
A Quick Ratio of 1.02 indicates that NMRK should not have too much problems paying its short term obligations.
The Quick ratio of NMRK (1.02) is worse than 63.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
NMRK Yearly Current Assets VS Current LiabilitesNMRK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.09% over the past year.
NMRK shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.83% yearly.
NMRK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.15%.
The Revenue has been growing slightly by 3.83% on average over the past years.
EPS 1Y (TTM)26.09%
EPS 3Y4.46%
EPS 5Y-6.83%
EPS Q2Q%22.22%
Revenue 1Y (TTM)12.15%
Revenue growth 3Y9.05%
Revenue growth 5Y3.83%
Sales Q2Q%11.3%

3.2 Future

Based on estimates for the next years, NMRK will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.99% on average per year.
The Revenue is expected to grow by 7.06% on average over the next years.
EPS Next Y11.82%
EPS Next 2Y15.82%
EPS Next 3Y14.79%
EPS Next 5Y10.99%
Revenue Next Year7.55%
Revenue Next 2Y10.28%
Revenue Next 3Y9.68%
Revenue Next 5Y7.06%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NMRK Yearly Revenue VS EstimatesNMRK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
NMRK Yearly EPS VS EstimatesNMRK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.89, the valuation of NMRK can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of NMRK indicates a rather cheap valuation: NMRK is cheaper than 88.52% of the companies listed in the same industry.
NMRK's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.29.
A Price/Forward Earnings ratio of 9.70 indicates a reasonable valuation of NMRK.
Based on the Price/Forward Earnings ratio, NMRK is valued cheaply inside the industry as 95.08% of the companies are valued more expensively.
NMRK is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.89
Fwd PE 9.7
NMRK Price Earnings VS Forward Price EarningsNMRK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

93.44% of the companies in the same industry are more expensive than NMRK, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.14
NMRK Per share dataNMRK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of NMRK may justify a higher PE ratio.
A more expensive valuation may be justified as NMRK's earnings are expected to grow with 14.79% in the coming years.
PEG (NY)1.01
PEG (5Y)N/A
EPS Next 2Y15.82%
EPS Next 3Y14.79%

4

5. Dividend

5.1 Amount

NMRK has a yearly dividend return of 0.91%, which is pretty low.
Compared to an average industry Dividend Yield of 4.56, NMRK pays a better dividend. On top of this NMRK pays more dividend than 81.97% of the companies listed in the same industry.
With a Dividend Yield of 0.91, NMRK pays less dividend than the S&P500 average, which is at 2.28.
Industry RankSector Rank
Dividend Yield 0.91%

5.2 History

The dividend of NMRK decreases each year by -13.90%.
NMRK has been paying a dividend for over 5 years, so it has already some track record.
NMRK has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-13.9%
Div Incr Years2
Div Non Decr Years3
NMRK Yearly Dividends per shareNMRK Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 0.1 0.2 0.3

5.3 Sustainability

39.59% of the earnings are spent on dividend by NMRK. This is a low number and sustainable payout ratio.
DP39.59%
EPS Next 2Y15.82%
EPS Next 3Y14.79%
NMRK Yearly Income VS Free CF VS DividendNMRK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B
NMRK Dividend Payout.NMRK Dividend Payout, showing the Payout Ratio.NMRK Dividend Payout.PayoutRetained Earnings

NEWMARK GROUP INC-CLASS A

NASDAQ:NMRK (1/21/2025, 8:17:10 PM)

After market: 13.79 0 (0%)

13.79

+0.5 (+3.76%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-05 2024-11-05/bmo
Earnings (Next)02-14 2025-02-14/amc
Inst Owners68.96%
Inst Owner Change-0.33%
Ins Owners12.41%
Ins Owner Change1.48%
Market Cap2.36B
Analysts78.18
Price Target19.04 (38.07%)
Short Float %4.11%
Short Ratio5.13
Dividend
Industry RankSector Rank
Dividend Yield 0.91%
Yearly Dividend0.12
Dividend Growth(5Y)-13.9%
DP39.59%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.35%
Min EPS beat(2)3.95%
Max EPS beat(2)8.75%
EPS beat(4)2
Avg EPS beat(4)1.84%
Min EPS beat(4)-3.36%
Max EPS beat(4)8.75%
EPS beat(8)3
Avg EPS beat(8)-1.38%
EPS beat(12)6
Avg EPS beat(12)3.97%
EPS beat(16)10
Avg EPS beat(16)12.75%
Revenue beat(2)0
Avg Revenue beat(2)-1.44%
Min Revenue beat(2)-1.48%
Max Revenue beat(2)-1.4%
Revenue beat(4)1
Avg Revenue beat(4)-0.62%
Min Revenue beat(4)-1.48%
Max Revenue beat(4)1.85%
Revenue beat(8)2
Avg Revenue beat(8)-1.18%
Revenue beat(12)5
Avg Revenue beat(12)0.16%
Revenue beat(16)9
Avg Revenue beat(16)4.46%
PT rev (1m)0.9%
PT rev (3m)15.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.72%
EPS NY rev (1m)0%
EPS NY rev (3m)2.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.12%
Valuation
Industry RankSector Rank
PE 11.89
Fwd PE 9.7
P/S 0.9
P/FCF N/A
P/OCF N/A
P/B 2.01
P/tB N/A
EV/EBITDA 9.14
EPS(TTM)1.16
EY8.41%
EPS(NY)1.42
Fwd EY10.31%
FCF(TTM)-1.35
FCFYN/A
OCF(TTM)-1.13
OCFYN/A
SpS15.27
BVpS6.84
TBVpS-1.12
PEG (NY)1.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.05%
ROE 4.47%
ROCE 4.91%
ROIC 2.47%
ROICexc 2.58%
ROICexgc 4%
OM 5.72%
PM (TTM) 2%
GM 98.92%
FCFM N/A
ROA(3y)5.78%
ROA(5y)4.47%
ROE(3y)22.9%
ROE(5y)19.37%
ROIC(3y)10.15%
ROIC(5y)8.54%
ROICexc(3y)11.84%
ROICexc(5y)9.76%
ROICexgc(3y)21.47%
ROICexgc(5y)17.54%
ROCE(3y)19.68%
ROCE(5y)16.35%
ROICexcg growth 3Y-14.45%
ROICexcg growth 5Y-20.33%
ROICexc growth 3Y-17.65%
ROICexc growth 5Y-21.59%
OM growth 3Y-23.16%
OM growth 5Y-20.65%
PM growth 3Y-22.41%
PM growth 5Y-19.06%
GM growth 3Y0.03%
GM growth 5Y0.04%
F-Score5
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF N/A
Debt/EBITDA 5.44
Cap/Depr 22.24%
Cap/Sales 1.48%
Interest Coverage 2.94
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 1.32
F-Score5
WACC7.7%
ROIC/WACC0.32
Cap/Depr(3y)29%
Cap/Depr(5y)25.7%
Cap/Sales(3y)1.74%
Cap/Sales(5y)1.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.09%
EPS 3Y4.46%
EPS 5Y-6.83%
EPS Q2Q%22.22%
EPS Next Y11.82%
EPS Next 2Y15.82%
EPS Next 3Y14.79%
EPS Next 5Y10.99%
Revenue 1Y (TTM)12.15%
Revenue growth 3Y9.05%
Revenue growth 5Y3.83%
Sales Q2Q%11.3%
Revenue Next Year7.55%
Revenue Next 2Y10.28%
Revenue Next 3Y9.68%
Revenue Next 5Y7.06%
EBIT growth 1Y-7.67%
EBIT growth 3Y-16.21%
EBIT growth 5Y-17.62%
EBIT Next Year103.28%
EBIT Next 3Y43.11%
EBIT Next 5Y27.72%
FCF growth 1Y-146.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-135.49%
OCF growth 3YN/A
OCF growth 5YN/A